Amyloidosis classification: Difference between revisions
Jump to navigation
Jump to search
Line 26: | Line 26: | ||
|- | |- | ||
|ATTRwt | |ATTRwt | ||
| | |Transthyretin-related amyloidosis, wild-type | ||
|Senile restrictive cardiomyopathy | |Senile restrictive cardiomyopathy | ||
|- | |- |
Revision as of 16:55, 9 May 2018
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amyloidosis classification On the Web |
American Roentgen Ray Society Images of Amyloidosis classification |
Risk calculators and risk factors for Amyloidosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Classification
Amyloidosis may be classified according to precursor amyloidogenic protein into different subtypes, include:
Name | Amyloidogenic protein | Clinical syndrome |
---|---|---|
AL | Monoclonal gammopathy | Light chains of immunoglobulines |
AA | Serum amyloid A protein | Chronic inflammation related amyloidosis |
AF | Mutant transthyretin, A1-apolipoprotein, gelsolin, fibrinogen, lysozyme, etc. | Familial polyneuropathy/cardiomyopathy/nephropathy |
ATTRwt | Transthyretin-related amyloidosis, wild-type | Senile restrictive cardiomyopathy |
AH | ß2-microglobulin | Dialysis-related amyloidosis |